Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1

Explore clinical trials studying Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 trial results

Recruiting

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT00801489

Conditions
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +19 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

NCT01253070

Conditions
Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +12 more
Locations
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 43 locations
View Trial Details

Related conditions